About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Identify A New Vaccine Candidate for Chikungunya Virus

by Rukmani Krishna on February 28, 2013 at 11:10 PM
 Researchers Identify A New Vaccine Candidate for Chikungunya Virus

A new method of vaccine creation for Chikungunya virus (CHIKV) using a technique called large scale random codon re-encoding was developed by researchers. This method has helped them modify nucleic acid composition of the virus without changing encoded viral proteins.

Using this approach, a group from the UMR_D 190, Emerging viruses Department in Marseille, France in collaboration with the University of Sydney, Australia, showed that the engineered viruses exhibit a stable phenotype with a significantly decreased viral fitness (i.e., replication capacity), making it a new vaccine candidate for the emerging viral disease.

Advertisement

When the large-scale codon re-encoding method was applied by Antoine Nougairede and his colleagues to poliovirus and Influenza A virus, it resulted in a live but attenuated virus that had significant reduction of viral fitness.

This study demonstrates that a random approach reduced the replicative fitness of CHIKV in both primate and arthropod cells.

The strategy also prevented the reversion of the attenuated phenotype by mutation or recombination, thus reducing the possibility that the newly created virus strain could evolve back to the pathogenic version.
Advertisement

The findings suggest that large-scale codon re-encoding can provide a strong basis for the rapid design of next-generation viral vaccines against emerging viral pathogens, as soon as their genome sequence has been determined.

It represents another route to vaccine development as it intrinsically alleviates the likelihood of novel pathogenic properties of the designed live vaccine, and allows modulation of the amount of reduced fitness by altering the terms and degree of the genetic re-encoding.

Thus, this strategy potentially allows for the generic development of live attenuated vaccines against many new viral pathogens, with reduced costs and the potential single dose induction of long-term immunity.

This report has been published in the Open Access journal, PLOS Pathogens.

Source: ANI
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Chikungunya News

Connection Between COVID-19 and Mortality Among Cancer Patients
Researchers evaluated whether systemic anticancer therapies and comorbidities were associated with COVID-19 mortality among adults with cancer and COVID-19.
Global Chikungunya Vaccine Phase II/III Trial Starts in Costa Rica
A multi-country study led by IVI in partnership with BBIL, funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology, India starts clinical trial on chikungunya vaccine.
Combination of Chikungunya and Zika Virus Linked to Stroke
Combination of zika virus and chikungunya virus is found to trigger stroke. Stroke following zika and chikungunya virus can be deadly and also result in death.
Gut Bacteria Reduces Severity of Mosquito-Borne Viral Infections
Healthy gut bacteria reduces the severity of mosquito-borne viral infections like chikungunya, by regulating inflammation and the body's response to infection. They help reduce the community spread of infection by disrupting the virus transmission from one person to another via mosquitoes.
Chikungunya Snapshot Aids to Design Drugs & Vaccines for Viral Arthritis
Structure of chikungunya virus promises to accelerate efforts to design drugs and vaccines to prevent or treat arthritis caused by chikungunya or related viruses.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Researchers Identify A New Vaccine Candidate for Chikungunya Virus Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests